相关实验视频
Updated: Sep 17, 2025

07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
43.9K
结尾蛋白-1和糖尿病诱导的勃起功能障碍:从致病源到治疗潜力
Hui Chen1, Zixiang Gao1, Xiangfa Lin1
1Department of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Diabetes research and clinical practice
|June 29, 2025
概括
糖尿病引起的勃起功能障碍 (DMED) 与Endothelin-1 (ET-1) 水平升高有关. 准ET-1为管理DMED和其他糖尿病并发症提供了一个有希望的治疗策略.
科学领域:
- 内分泌学 在内分泌学.
- 血管生物学 血管生物学
- 糖尿病学 糖尿病学
背景情况:
- 糖尿病引起的勃起功能障碍 (DMED) 是糖尿病的一个重要并发症.
- 血管内皮损伤在DMED的发病过程中起着至关重要的作用.
- 内皮素-1 (ET-1) 是一种血管收缩剂,与糖尿病内皮功能障碍有关.
研究的目的:
- 审查ET-1在DMED病变发生中的作用.
- 探索高血糖高调节ET-1的机制.
- 讨论针对ET-1进行DMED治疗的治疗策略.
主要方法:
- 对ET-1和DMED的临床和实验研究的审查.
- 分析影响ET-1水平的信号通路和表观遗传变化.
- 检查ET-1对炎症,氧化应激和氧化物 (NO) 生物可用性的影响.
主要成果:
- 高血糖症通过各种机制显著增加ET-1水平,包括表观遗传修饰.
- 升高的ET-1通过促进炎症,氧化应激和减少NO,促进DMED.
- 临床和实验数据支持ET-1失调和DMED之间的联系.
结论:
- ET-1失调是DMED病变的一个关键驱动因素.
- 准ET-1合成或其受体为DMED提供了一种可行的治疗方法.
- 对ET-1调制的进一步研究可能会改善DMED和其他糖尿病并发症的治疗方法.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
227
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
227
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
255
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
255
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
905
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
905
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Hypertension II: Pathophysiology
90
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
90

